Exact Sciences Launches Colorectal Cancer Screening Study | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Exact Sciences today said that it has begun enrollment in a pivotal study of its multi-marker, molecular colorectal cancer screening test.

The Madison, Wis.-based firm said that it plans to carry out the study at 60 sites in the US and Canada. It expects those sites will enroll more than 10,000 patients between the ages of 50 and 84 who are at average risk for developing colorectal cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.